Private Advisor Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,967
| Closed | -$287K | – | 1917 |
|
|
2022
Q2 | $287K | Sell |
1,967
-1,505
| -43% | -$220K | ﹤0.01% | 1669 |
|
|
2022
Q1 | $567K | Sell |
3,472
-353
| -9% | -$57.6K | ﹤0.01% | 1363 |
|
|
2021
Q4 | $649K | Sell |
3,825
-1,149
| -23% | -$195K | ﹤0.01% | 1319 |
|
|
2021
Q3 | $940K | Buy |
4,974
+2,750
| +124% | +$520K | 0.01% | 1240 |
|
|
2021
Q2 | $377K | Buy |
2,224
+788
| +55% | +$134K | ﹤0.01% | 1529 |
|
|
2021
Q1 | $203K | Buy |
+1,436
| New | +$203K | ﹤0.01% | 1730 |
|
|
2020
Q3 | – | Sell |
-693
| Closed | -$103K | – | 1623 |
|
|
2020
Q2 | $103K | Buy |
+693
| New | +$103K | ﹤0.01% | 1690 |
|